文章摘要
贾永华,张延杰,周延生,王成山,颜彬.通癃胶囊治疗前列腺增生症的临床研究[J].南京中医药大学学报(社会科学版),2006,22(5):290-293.
通癃胶囊治疗前列腺增生症的临床研究
Clinical Study on Treatment of Hyperplasia of Prostate with Tonglong Capsule
投稿时间:2006-05-25  修订日期:2006-06-25
DOI:
中文关键词: 通癃胶囊,前列腺增生,前列康
英文关键词: Tonglong Capsule,hyperplasia of prostate,Qianliekang
基金项目:连云港市卫生局科研项目(05036)
贾永华  张延杰  周延生  王成山  颜彬
江苏省东海县中医院 江苏东海222300(贾永华,张延杰,周延生,王成山)
,江苏省东海县人民医院 江苏东海222300(颜彬)
摘要点击次数: 1338
全文下载次数: 1
中文摘要:
      目的探讨通癃胶囊治疗良性前列腺增生症(BPH)的疗效与安全性。方法90例BPH患者随机分为治疗组60例与对照组30例,治疗组口服通癃胶囊,对照组服用前列康,治疗90 d后评定疗效。结果治疗组降低患者的IPSS评分、提高最大尿流率、减少膀胱残余尿量与对照组比较有显著性差异(P<0.01);缩小患者的前列腺体积与对照组比较有显著性差异(P<0.05)。治疗组治疗前后的性激素测定结果表明:腺体缩小组中,E2治疗后下降,E2/T比值下降,与腺体未缩小组比较有显著性差异(P<0.05)。2组治疗期间均无严重不良事件发生。结论口服通癃胶囊治疗BPH疗效显著,无严重不良反应。
英文摘要:
      OBJECTIVE To investigate into the effect and safety of Tonglong Capsule in the treatment of hyperplasia of prostate.METHOD 90 patients were randomly divided into a treatment group of 60 patients and a control group of 30 patients,who took Tonglong Capsule and Qianliekang tablet respectively for 90 days.RESULT Marked differences were found between the two groups in IPSS decrease rating,maximum urine flow increase and residual urine volume decrease(P<0.01),and also in prostate volume reduction(P<0.05).The result of sex hormone determination indicated that in the group with prostate volume reduction,E_2 and E_2/T ratio decreased,with marked difference as compared with the group without prostate volume reduction(P<0.05).No serious undesirable accident occurred in both group.CONCLUSION Tonglong Capsule is very effective for hyperplasia of prostate,with no serious side effect.
查看全文   查看/发表评论  下载PDF阅读器
关闭
微信公众号